Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FILGRASTIM-SNDZ for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where FILGRASTIM-SNDZ was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for FILGRASTIM-SNDZ

Side Effect Reports % Deaths Hosp.
Death 505 29.5% 501 8
White blood cell count decreased 79 4.6% 1 11
Hospitalisation 68 4.0% 0 61
Neoplasm malignant 62 3.6% 23 2
Bone pain 61 3.6% 1 8
Pain 39 2.3% 0 5
Malaise 38 2.2% 2 3
Pyrexia 38 2.2% 2 17
Fatigue 37 2.2% 2 4
Drug ineffective 32 1.9% 3 4
Dyspnoea 30 1.8% 1 10
Full blood count decreased 30 1.8% 0 7
Back pain 29 1.7% 0 3
Illness 28 1.6% 1 4
Nausea 26 1.5% 1 6

Other Indications for FILGRASTIM-SNDZ

Product used for unknown indication (941) Neutropenia (113) Agranulocytosis (55) Breast cancer female (47) White blood cell count decreased (24) Chemotherapy (23) Neoplasm malignant (22) Plasma cell myeloma (17) Acute myeloid leukaemia (16) Lung neoplasm malignant (13)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

FILGRASTIM-SNDZ Full Profile All Diffuse large b-cell lymphoma Drugs FILGRASTIM-SNDZ Demographics FILGRASTIM-SNDZ Timeline